DTC

Willow2002_

So from what I’m seeing you’re more talking about a low float volatility play because there’s decently high volume in the stock compared to SI = low DTC. But what you’re more focused on is the float being small, probs due to insider ownership being so high. But yeah I see this as something that could jump up. Do you know of any catalysts that could set stuff off a bit.

plasticbug

Ultimately, you are trusting DTC, and the fact federal government will not allow it to fail.

The_Insider_Edge

Will turn up with DTC, they just got OTCQB give it a week

Inevitable_Fuel7244

Depends on the specific product/business we're working with but speaking generally if you were to invest money this is the order you would do it: 1. Meta (FB/IG) 2. Google Ads (search/shopping) 3. YouTube Ads You can basically run a brand making over $100 mil a year in rev off those channels alone. Most brands never need to grow beyond that mix. It's the trifecta. Works for your homies shitty little clothing startup, works for big DTC brands like hexclad etc. Those channels are often also paired with working with some influencers either small or large to help produce ad content. From there it really depends on the brand and our strategy but thats when we'd start to look at: 4. TikTok 5. Bing 6. Traditional TV (brand dependent) 7. Direct mailers (brand dependent) Then from there is when we might start to look at Reddit lol.

The_Insider_Edge

They need DTC then the volume will come quickly

94ChevyCavalier

Don’t sleep on $PDYN Quick data points to look at indicating short term volatility and indications that the squeeze is actually yet to happen-  JAN 28-70 million in volume  Combined volume of preceding 3 months was less than that one day  Short interest since then flat at 22%  Short borrow fee was steady at around 4 and through the end of the week rocketed to 40  Average trading volume is 3 million making actual DTC closer to 3 days and rising Seller pressure has lost momentum but shorts are still entrenched with virtually no price change between Tuesdays close and Friday’s close Engage with this stock. A squeeze is likely with proper engagement and interest.  The company has a 2 year runway, and will be revising estimates higher, earnings will be a major catalyst. I intend to hold long but near term this is highly attractive. Someone, likely institutional, is betting hard on PDYN to decline. I don’t like people who bet the DONT line when I’m on the table. I do, however like the stock.

Wimea

I'm on my phone so excuse the formatting. Which broker is this? I've seen this fee when attempting to buy stocks that cannot be settled by US DTC. If the stock is not sponsored through any of the major US exchanges then a broker would have to manually do it hence the fee. Best you call your brokerage and ask.

hab365

Yeah, and most of SpaceX’s value comes from Starlink rather than from launch and they’re having more and more competition there, whether it be internet or DTC

Changeuplife

ASBP- Agreement signed, low float, high shorts and over 25 DTC. Another sqeeze potential. Just bought in

Changeuplife

DCX - VERY low float, high shorts with over 12 DTC! News and volume huge! Let's make a run on this...EVERYONE

IndividualNo7155

What’s the SI and DTC tho? Can’t find it

Changeuplife

GRI - News, float under 1M, high short % and DTC over 4. We could push this quite high! Buy the dip

Changeuplife

HIND - News, massive volume over 90 days, only 3M float and DTC 2.64. Coming down from its highs, buy on the dip. Might wait until open to pounce on this one.

Changeuplife

mbai - news with massive volume and DTC almost 6, low float. Buy the dip

Changeuplife

Not a penny but check out LE. Great news, low float, volume increasing and DTC shorts is 9 days! This could be a good entry point for a couple day play! Wait for the open to see where it lands and find a comfortable entry point.

Changeuplife

Not seeing it! Good news, yes, but very low volume on this news and no potential for any sqeeze. DTC .15. Maybe longer term hold.

zhabesha

Maybe that’s why they are moving away from DTC to insurance?

RedPlumpTomato

Enjoy my AI Slop Analysis! CYCU - Cycurion, Inc. / Information Technology Services | United States | $8.9M Market Cap Technology QUICK STATS Price: $2.46 | Float: 2.4M (nano-float) Day: -3.53% | Week: -9.56% | Month: -14.58% 52w: $2.11 - $323.87 (currently -99% from high) ATH: $323.87 (down 99%) IPO: Feb 2025 (11 months old) BULL THESIS Cybersecurity company with recent $1.1M contract win. Analyst target $7.00 (+185% upside). Nano-float (2.4M) means any volume could move it significantly. Trading near 52w low ($2.11) - could be bottoming. BEAR THESIS Down 99% from ATH - classic pump and dump pattern. Massive dilution (+572% shares outstanding). Serial diluter with 6 offerings in 1 year. Burning cash (-111% profit margin). Very low institutional interest (2.8%). All timeframes negative. Volume dying. FUNDAMENTALS Debt/Equity: 0.59x (moderate) Short Interest: 11.3% (2.4 DTC) Institutional: 2.8% (very low) Profit Margin: -111% (burning cash) Analyst Target: $7.00 (+185% upside, 1 analyst) RED FLAGS \- Shares +572% (extreme dilution) \- Serial diluter: 6 offerings in 1 year \- Down 99% from ATH \- Volume dying (0.1x average) \- All timeframes negative CHART: BEARISH (-35 pts) Falling knife pattern. 6-month downtrend (-79%). Volume dying. THESIS HEALTH: BROKEN (0/100) \- 2 negative headlines \- 7 positive headlines \- Recent: Won $1.1M contract but stock still falling SEC STATUS: CAUTION Serial diluter with 6 offerings in past year. VERDICT: AVOID High risk. Down 99% from ATH with massive dilution history. All timeframes bleeding. Very low institutional interest. The $1.1M contract win is noise - fundamentals are broken. LEVELS Support: $2.11 (52w low / ATL) Resistance: $3.50 (recent) Not financial advice. DYOR.

RedPlumpTomato

My AI Slop Analysis! LEXX - Lexaria Bioscience Corp Healthcare/Biotech | Canada | $21M Market Cap QUICK STATS Price: $0.85 | Float: 23.5M Month: +52% | Week: +12% | Day: +4% 52w: $0.46 - $1.91 (currently -56% from high) ATH: $12.50 (down 93%) BULL THESIS Biotech with patented drug delivery technology (DehydraTECH). Phase trials ongoing. Analysts see 4-5x upside. Nano-float (23.5M) means any volume spike could move price significantly. Recent momentum (+52% month) suggests accumulation may be starting. BEAR THESIS Serial diluter - 8 offerings in one year, shares up 27%. Down 93% from ATH. Very low institutional interest (7%) - smart money not buying. Shelf registration active means more dilution likely coming. Could be a value trap. FUNDAMENTALS Debt/Equity: 0.02x (healthy) Short Interest: 6.7% (low, 1.2 DTC) Institutional: 7.1% (very low) Analyst Target: $4.50 (+429% upside, 3 analysts) RED FLAGS \- Serial diluter: 8 offerings in past year \- Shares +27% (dilution) \- Shelf registration active \- Down 93% from ATH CHART: BEARISH Falling knife pattern. Recent +52% spike may be late entry. SENTIMENT Minimal discussion. First mentioned Dec 2025 at $1.34, now -37%. VERDICT: NEUTRAL No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. LEVELS Support: $0.46 (52w low) Resistance: $1.91 (52w high) Not financial advice. DYOR.

RedPlumpTomato

My AI Slop Analysis **LEXX - Lexaria Bioscience Corp** Healthcare/Biotech | Canada | $21M Market Cap **Quick Stats** Price: $0.85 | Float: 23.5M Month: +52% | Week: +12% | Day: +4% 52w: $0.46 - $1.91 (currently -56% from high) ATH: $12.50 (down 93%) **Bull Thesis** Biotech with patented drug delivery technology (DehydraTECH). Phase trials ongoing. Analysts see 4-5x upside. Nano-float (23.5M) means any volume spike could move price significantly. Recent momentum (+52% month) suggests accumulation may be starting. **Bear Thesis** Serial diluter - 8 offerings in one year, shares up 27%. Down 93% from ATH. Very low institutional interest (7%) - smart money not buying. Shelf registration active means more dilution likely coming. Could be a value trap. **Fundamentals** Debt/Equity: 0.02x (healthy) Short Interest: 6.7% (low, 1.2 DTC) Institutional: 7.1% (very low) Analyst Target: $4.50 (+429% upside, 3 analysts) **Red Flags** Serial diluter: 8 offerings in past year Shares +27% (dilution) Shelf registration active Down 93% from ATH **Chart: Bearish** Falling knife pattern. Recent +52% spike may be late entry. **Sentiment** Minimal discussion. First mentioned Dec 2025 at $1.34, now -37%. **Verdict: Neutral** No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop.

RedPlumpTomato

# LEXX - Lexaria Bioscience Corp **Healthcare/Biotech | Canada | $21M Market Cap** ## Quick Stats - Price: $0.85 | Float: 23.5M - Month: +52% | Week: +12% | Day: +4% - 52w: $0.46 - $1.91 (currently -56% from high) - ATH: $12.50 (down 93%) ## Fundamentals - Debt/Equity: 0.02x (healthy) - Short Interest: 6.7% (low, 1.2 DTC) - Institutional: 7.1% (very low) - Analyst Target: $4.50 (+429% upside, 3 analysts) ## Red Flags - Serial diluter: 8 offerings in past year - Shares +27% (dilution) - Shelf registration active - Down 93% from ATH ## Chart: Bearish - Falling knife pattern - Recent +52% spike may be late entry ## Sentiment - Minimal discussion (1 post in 7 days) - First mentioned Dec 2025 at $1.34, now -37% ## Verdict: Neutral No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. ## Levels - Support: $0.46 (52w low) - Resistance: $1.91 (52w high) *Not financial advice. DYOR.* My AI Slop Analysis!

RedPlumpTomato

# LEXX - Lexaria Bioscience Corp **Healthcare/Biotech | Canada | $21M Market Cap** ## Quick Stats - Price: $0.85 | Float: 23.5M - Month: +52% | Week: +12% | Day: +4% - 52w: $0.46 - $1.91 (currently -56% from high) - ATH: $12.50 (down 93%) ## Fundamentals - Debt/Equity: 0.02x (healthy) - Short Interest: 6.7% (low, 1.2 DTC) - Institutional: 7.1% (very low) - Analyst Target: $4.50 (+429% upside, 3 analysts) ## Red Flags - Serial diluter: 8 offerings in past year - Shares +27% (dilution) - Shelf registration active - Down 93% from ATH ## Chart: Bearish - Falling knife pattern - Recent +52% spike may be late entry ## Sentiment - Minimal discussion (1 post in 7 days) - First mentioned Dec 2025 at $1.34, now -37% ## Verdict: Neutral No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. ## Levels - Support: $0.46 (52w low) - Resistance: $1.91 (52w high) *Not financial advice. DYOR.* Here is my AI Slop Analysis!

Murky-Pin7299

So what numbers are we potentially looking at? Trading at $1.30 right now on IBKR. Today’s range 1.19-1.46. Volume 650k. Shortable shares 53,700. Days to cover 0.3. DTC too low to squeeze just yet.

ryzetard

and as I mentioned earlier DTC just plummeted to \~1 so any covering theoritically takes one day so not much of a squeeze can happen.

ryzetard

where do you see this short interest and DTC? i keep asking yet no one is able to respond. Are you all aware of the reverse split on it or not?

theoldme3

The stock market should work on simple supply and demand. Not some algorithm controlled by shit bags who are already rich. It has been manipulated for way too long and FINRA, SEC, DTC, DTCC and all those other bull shit, alphabet named regulators, are in on it.

ryzetard

i know you are hyped but just think critically for a moment. the latest DTC/SI data is for 31st December as per Nasdaq itself. Look at the recent volume spike and ask yourself - how much more liquid is this stock now considering that.

its-me__

DTC is interesting but i agrees FTD and borrow rate both are not that bullish

CanadianSneakerNut

Yahoo is fine, but upgrading your data sources is a game‑changer. I’m a big TradingView fan — didn’t realize how much I was missing until I grabbed it on a Black Friday deal. The data is cleaner, deeper, and way easier to work with. FIGS’ slowest YoY growth was 2024 → 2025, but even in a rough economy they still managed +1.8% revenue. Quarterly breakdown for 2025 tells the real story: soft Q1, strong Q2 rebound, and net margins improving every quarter through Q3. Balance sheet is solid too. Cash + equivalents almost cover total debt, and both short‑ and long‑term assets comfortably outweigh liabilities. There’s way more to this story than just the P/E ratio. FIGS is a niche brand with a loyal customer base, strong DTC economics, and a balance sheet that gives them room to operate. They’re not growing hyper‑fast anymore, but they’re executing well in a tough retail environment. Momentum traders might not love the slower growth, but fundamentally this isn’t the kind of company I’d be lining up to bet against. I wouldn’t open a massive position at current levels, but calling FIGS a short just because the P/E looks high feels like surface‑level analysis.

skinnyjoints

DTC is sitting at 7 currently. You are right though. The float is tiny so any volume is going to drop the days to cover to near zero. But the tiny float is going to make it difficult and expensive for any shorts to cover.

East-Description-243

Ya they work but the launch service that they NEED to successfully pull off the massive task of launching these satellites is raising safety concerns and is also their competitor and also already offering service DTC service! They will have voice and data before Asts even has minimal amount of satellites for any commercial service, mark my words. You all are in hopes and dreams and this point bro.

East-Description-243

Starlink already has DTC text and emergency through T-Mobile. ASTS still needs 20 more satellites deployed before beta service. They’ve only launched 6 satellites since sept 2023.

_ii_

I think you don’t yet have a firm grip on the terms: ~Private Bank~, ~FDIC Insured~, and ~Stock~. Private bank customers usually need to have more than 5 digit balance. To take advantage of private bank, you typically have someone do the transactions for you, otherwise it’s the same as any other brokerage account. FDIC is for bank deposits, not stocks. Stock is a claim to the company. You lose it by the company getting out of business. FDIC won’t help. Robinhood doesn’t buy the stock and keep it in their stockroom for you. Technically the cleaning house (DTC) “hold” the stock for you by updating their electronic records. Robinhood does some bookkeeping and communication with exchanges where actual trading took place. This is also how Robinhood makes money - selling your order flow.

East-Description-243

Starlink partnered with T Mobile and already has DTC text and emergency and voice/data coming soon. They are a year and a half in with service and ASTS hasn’t even launched the satellites to do any significant testing with ATT or Verizon.

skinnyjoints

Your AI summary is not correct. Current DTC is 2.8 days. I encourage you to do your own research especially when it only takes 10 seconds to verify. [Volume data](https://www.nasdaq.com/market-activity/stocks/bbgi/historical) [That volume data already used to calculate DTC for you](https://fintel.io/ss/us/bbgi)

Front_Requirement598

BBGI's short interest has seen recent significant increases, with ~113,000 shares shorted (around 13.3% of float) as of mid-December 2025, indicating growing bearish sentiment, although the Days to Cover (DTC) ratio is very low (near 0.0), suggesting high trading volume relative to short positions, making a traditional short squeeze less likely without a major shift in volume. END AI SUMMARY

justreadinplease

DTC was a flop because when they left local brick and mortar stores competitors moved in and suddenly all their old consumers couldn’t try on Nikes, but they could try on all these other brands. It’s not like Dick Sporting Goods or Hibbet Sports or whatever is going to leave their shelves bare. Nike tried to open a ton of stores, but trying to keep a store profitable when only selling one brand and also keeping a store up to Nike standards is hard. Nike is also not going to open a store in some small town where they can’t gross more than $5million in a location, but all those small podunk towns add up. Not being in those brand partners’ stores hurt - a death of a thousand cuts over time.

AntoniaFauci

Do you know why their DTC was such a flop? I didn’t follow it but on paper it seems like it would have been sensible. Consumers no longer caring where they buy or who fulfills the order, they just see a picture and want to click and receive the product. Nike owning the whole margin instead of splitting it with Foot Locker or Amazon. If I were given that pitch I’d say that sounds like as good a strategy as any. So what went wrong?

Full_Implement_2900

Nike’s DTC strategy is probably the biggest fiasco for a sportsbrand business wise the last 6-7 years. I remember reading about it in their reports back in 2018-2019

Nice-Beginning-7943

MEHA $0.23 DD, OS 16.25 million, Recent IPO from 11/5 at $8 a micro-cap company in the nutraceutical and wellness supplements space: • Established Legacy Brand: The company is built around Kirkman®, a trusted brand with over 75 years of history, sold in 35+ countries. It has a strong reputation for high-quality, hypoallergenic supplements, particularly in specialty areas like immunity, detox, and prenatal health. • Innovative Product Differentiation: The P2i™ by Kirkman® prenatal multivitamin stands out as the world’s first to fully align with International Federation of Gynecology and Obstetrics (FIGO) transparency standards for toxic chemicals and contaminants. It’s also the first to comply early with California’s SB 646 law (effective 2027), featuring QR codes linking to batch-specific test results for heavy metals, toxins, allergens, and more. This positions it as a leader in clean, transparent prenatal supplements amid growing consumer demand for safety and purity. https://finance.yahoo.com/news/functional-brands-inc-announces-p2i-130000920.html • Recent Growth Momentum: Q3 2025 results showed revenue up 21.4% year-over-year to $1.7M, driven by direct-to-consumer sales. Gross margins improved by 310 basis points to 57.8%, and the company swung to a profitable net income of $0.3M (vs. a loss last year). Over recent years, annual revenue has been stable around $6.5-6.8M with significant margin expansion (1,300 basis points). https://finance.yahoo.com/news/functional-brands-announces-third-quarter-210500607.html • Strategic Initiatives for Expansion: Partnerships like the one with Market Performance Group aim to accelerate eCommerce and digital growth for the Kirkman brand. Recent launches include a Skin, Beauty & Anti-Aging Bundle, and plans for direct Amazon management, a DTC telehealth platform (Tru2U), and Google-supported digital efforts to boost margins and reach. https://finance.yahoo.com/news/functional-brands-inc-launches-kirkmans-130000308.html • Nasdaq Listing and Visibility: Direct listing on Nasdaq in November 2025 enhances credibility, liquidity, and access to capital for “aggressive expansion” in the booming global health & wellness market. • Potential Undervaluation: With a market cap around $4M and enterprise value ~$5-6M, it trades at a low multiple relative to revenue (Price/Sales ~0.25). In a sector with strong tailwinds (rising demand for premium, science-backed supplements), successful execution on growth plans could offer significant upside for risk-tolerant investors.

Nice-Beginning-7943

MEHA $0.23 DD, OS:16.25 million, Recent IPO on 11/5 at $8 a micro-cap company in the nutraceutical and wellness supplements space: • Established Legacy Brand: The company is built around Kirkman®, a trusted brand with over 75 years of history, sold in 35+ countries. It has a strong reputation for high-quality, hypoallergenic supplements, particularly in specialty areas like immunity, detox, and prenatal health. • Innovative Product Differentiation: The P2i™ by Kirkman® prenatal multivitamin stands out as the world’s first to fully align with International Federation of Gynecology and Obstetrics (FIGO) transparency standards for toxic chemicals and contaminants. It’s also the first to comply early with California’s SB 646 law (effective 2027), featuring QR codes linking to batch-specific test results for heavy metals, toxins, allergens, and more. This positions it as a leader in clean, transparent prenatal supplements amid growing consumer demand for safety and purity. https://finance.yahoo.com/news/functional-brands-inc-announces-p2i-130000920.html • Recent Growth Momentum: Q3 2025 results showed revenue up 21.4% year-over-year to $1.7M, driven by direct-to-consumer sales. Gross margins improved by 310 basis points to 57.8%, and the company swung to a profitable net income of $0.3M (vs. a loss last year). Over recent years, annual revenue has been stable around $6.5-6.8M with significant margin expansion (1,300 basis points). https://finance.yahoo.com/news/functional-brands-announces-third-quarter-210500607.html • Strategic Initiatives for Expansion: Partnerships like the one with Market Performance Group aim to accelerate eCommerce and digital growth for the Kirkman brand. Recent launches include a Skin, Beauty & Anti-Aging Bundle, and plans for direct Amazon management, a DTC telehealth platform (Tru2U), and Google-supported digital efforts to boost margins and reach. https://finance.yahoo.com/news/functional-brands-inc-launches-kirkmans-130000308.html • Nasdaq Listing and Visibility: Direct listing on Nasdaq in November 2025 enhances credibility, liquidity, and access to capital for “aggressive expansion” in the booming global health & wellness market. • Potential Undervaluation: With a market cap around $4M and enterprise value ~$5-6M, it trades at a low multiple relative to revenue (Price/Sales ~0.25). In a sector with strong tailwinds (rising demand for premium, science-backed supplements), successful execution on growth plans could offer significant upside for risk-tolerant investors.

Nice-Beginning-7943

MEHA $0.23 DD, OS 16.25m, Recent IPO 11/5 @$8 a micro-cap company in the nutraceutical and wellness supplements space: • Established Legacy Brand: The company is built around Kirkman®, a trusted brand with over 75 years of history, sold in 35+ countries. It has a strong reputation for high-quality, hypoallergenic supplements, particularly in specialty areas like immunity, detox, and prenatal health. • Innovative Product Differentiation: The P2i™ by Kirkman® prenatal multivitamin stands out as the world’s first to fully align with International Federation of Gynecology and Obstetrics (FIGO) transparency standards for toxic chemicals and contaminants. It’s also the first to comply early with California’s SB 646 law (effective 2027), featuring QR codes linking to batch-specific test results for heavy metals, toxins, allergens, and more. This positions it as a leader in clean, transparent prenatal supplements amid growing consumer demand for safety and purity. • Recent Growth Momentum: Q3 2025 results showed revenue up 21.4% year-over-year to $1.7M, driven by direct-to-consumer sales. Gross margins improved by 310 basis points to 57.8%, and the company swung to a profitable net income of $0.3M (vs. a loss last year). Over recent years, annual revenue has been stable around $6.5-6.8M with significant margin expansion (1,300 basis points). • Strategic Initiatives for Expansion: Partnerships like the one with Market Performance Group aim to accelerate eCommerce and digital growth for the Kirkman brand. Recent launches include a Skin, Beauty & Anti-Aging Bundle, and plans for direct Amazon management, a DTC telehealth platform (Tru2U), and Google-supported digital efforts to boost margins and reach. • Nasdaq Listing and Visibility: Direct listing on Nasdaq in November 2025 enhances credibility, liquidity, and access to capital for “aggressive expansion” in the booming global health & wellness market. • Potential Undervaluation: With a market cap around $4M and enterprise value ~$5-6M, it trades at a low multiple relative to revenue (Price/Sales ~0.25). In a sector with strong tailwinds (rising demand for premium, science-backed supplements), successful execution on growth plans could offer significant upside for risk-tolerant investors.

Front_Requirement598

For AEHL (Antelope Enterprise Holdings), short interest has recently dropped significantly (down ~87% from mid-November to mid-December 2025), with ~28% of the float sold short as of mid-December, a high level indicating pessimism, but a very low days-to-cover (0.5-0.51 days), meaning short positions could be covered quickly, making a significant squeeze less likely despite the high percentage. DTC (Days to Cover) is extremely low, around 0.5 days, suggesting high liquidity for shorts to exit. END AI SUMMARY

Ok_Strain_1624

So literally no content or value other than DTC advertising. Can't even watch a 15 second video to giggle at now, just straight up corporate slop masquerading as AI slop.

mod_cat

I have most often seen the $50 charge is the same (between Fidelity and Schwab) for the same security. I think a couple times I have seen it where one didn't charge the $50 and the other did (but I could be wrong). I don't really understand how they decide. I have bought some foreign ADRs (with the symbol ending in F) that don't have that fee and others that do. In general the largest stocks don't have it but for the small companies that do it isn't consistent (some have the fee, some don't). I imagine there is some reason but never bothered to look until now... "Some foreign stocks traded on the OTC market aren’t eligible for clearing through the Depository Trust Company (DTC). This means that transferring these non-DTC-eligible securities incurs extra costs for Fidelity. In turn, they pass on these fees to cover the associated expenses." https://usefidelity.com/fidelity-charges-50-for-foreign-settlement-fee-heres-why/

Front_Requirement598

AI SUMMARY: As of late November 2025, Vivakor (VIVK) had significant short interest, with around 9.41 million shares sold short, representing roughly 11% of the float, a decrease from the prior month, resulting in a very low Days to Cover (DTC) around 0.3 to 0.4 days, indicating high trading volume relative to short positions, making it less prone to a typical short squeeze despite the high percentage.

Bornagainghostbuster

FLWS is the best current play right now, whether it squeezes or not is anyones guess. Most potential though by far. Can't believe this sub isn't all over 100% shorted and 5 DTC.

LCGfunding

Someone can do it with money of course like DTC drop shipping platform can compete like Temu. High prices will force people to go temu. given opporttemp Temu will cut a share of amzn incrementally. Its the consumer base, prime/speed of shipping that made the difference with loyal customers.

Difficult_Winner_777

Tiny float doesn’t mean squeeze by itself. SI is ~4% with 0.10 DTC, and CMCT is actively issuing common for preferred redemptions per recent 8-Ks. Pops are possible, but this isn’t a trapped-short setup or “next SMX.”

Scquwer

Overall good week $VIPZ, looks like the legacy seller is out, they were pushing hard since the beginning of the month. Looks like the last trench, maybe went in early this week but now it’s stable and now nicely starting to climb back up. DTC hasn’t changed for a long time no shenanigans. Float pretty locked, just basic OTC market maker Algo’s doing their thing on lower volume, but once there’s pressure should be nice. Looking forward to what Les and team can accomplish in 2026!

_hiddenscout

Company basically has had declining revenue every quarter since May 2023.  Also negative EPS growth.  Seems like a lot of the investment and how heavy they went into DTC and cutting back on innovation really hurt them. 

Pretty_Apartment3511

0.1 days to cover. Good short interest and low float, however due to the high trading volume and the fact their DTC are so low makes it difficult. Still possible, just difficult.

OutlandishnessUsed24

Thats not true, the long term thesis is just to help elevate people from bankruptcy risk. Again, for 10000000 time, this company is already priced at bankruptcy so unless it DOES go bankrupt its only up from here. My DD is evolving all day as I get deeper. I have been following this stock all week but next week is my timing theory on shorts covering with no ammo for supply of share (all shares are held internally or by family, no convertable debt, no risk to share issuance, and nore more shares to short) Besides my 5 points below, the real critical piece is section 3 on this DD. You dont have to listen to me, if I am wrong we will see this week on the 1st half of my thesis. Come back here on Thursday/Friday :) 1.    94.82% of Float is Short — Near-total saturation of available shares 2.    TRUE Days to Cover: 53.7 days — The reported 4.14 DTC is misleading (see Section 2) 3.    Borrow inventory collapsed 84% — From 3.1M to 500K and has NOT recovered 4.    FINRA Exempt shorting spiked 26x on Dec 10 — 7.4-sigma event, statistically significant MM intervention 5.    Shorts ADDED 200K shares during Dec 9-12 — They're digging deeper, not covering Section 3 on my 13 page DD on my local drive is particularly interesting to me. Do what you want with my advice, it makes no difference to me https://preview.redd.it/cpwi8c2p547g1.png?width=1920&format=png&auto=webp&s=f940c8f250cacd7b098c0d817f8d66fb35f52c2c #

OutlandishnessUsed24

This is the right call. FLWS has a much cleaner setup than SGBX. Here's the data as of this weekend: **Borrow availability:** * Started last week at 3.2M * Thursday morning: dropped to 600K after shorts borrowed 2.6M to attack * Saturday overnight: dropped again to **500K** * Someone borrowed 100K shares on a weekend ahead of Monday **The imbalance:** * 9.4M shares short (FINRA) * 500K available to borrow * That's **18.8x imbalance** **What happened Thursday:** Shorts threw 2.5M shares at it in a concentrated attack and only got a 9% drop. Price held $3.90 support. They used 84% of their ammo and barely moved it. **What's different from SGBX:** * SGBX float expanded (dilution), FLWS hasn't diluted * SGBX insiders selling, FLWS insiders just got granted 133K shares (accumulating) * SGBX DTC < 1 day, FLWS has almost no shares available to cover with * SGBX no catalyst, FLWS just hired AI-focused CIO Dec 8 (stock popped 30%) **The part people are missing:** Even without the squeeze, FLWS is a $1.7B revenue company trading at $285M market cap (0.17x sales). That's priced for bankruptcy - but they're not going bankrupt. $93M EBITDA last year, new leadership team (first non-family CEO ever), and the McCann family owns \~42% and isn't selling. So the way I see it: * Squeeze works → big win * Squeeze doesn't work → I own a $2B revenue company at all-time lows SGBX doesn't have that floor. Sources: [Fintel](https://fintel.io/ss/us/flws) | [iBorrowDesk](https://iborrowdesk.com/report/FLWS)

ryzetard

if it has some strong earnings this year... volume keeps dropping, short interest stays high so DTC increases, insiders still keep the shares so i dont think they are very afraid of being deficient at the moment and low float.

ryzetard

depending on which source you trust the most: [https://fintel.io/ss/us/sgbx](https://fintel.io/ss/us/sgbx) [https://www.marketwatch.com/investing/stock/sgbx](https://www.marketwatch.com/investing/stock/sgbx) (btw seems they diluted, their previous outstanding shares were 5.6 million approximately as per their latest SEC filing - not a surprise cuz they are doing really bad recently) [https://finviz.com/quote.ashx?t=SGBX&p=d](https://finviz.com/quote.ashx?t=SGBX&p=d) [https://finance.yahoo.com/quote/SGBX/key-statistics/](https://finance.yahoo.com/quote/SGBX/key-statistics/) Float is everywhere more or less in line, short interest is in like 10-20% territory only, volume is high so DTC is less than 1 day on average. no way it can run

ryzetard

ok i worded it very poorly, apologies I didnt want to say that exactly you still promote bynd, i meant that sgbx is becoming bynd 2.0 and i have no clue why sgbx is still even mentioned. most sites confirm the float expanded which is in line with insiders and insitutions selling their holdings, true SI is lower, DTC is like 0.1-1 tops, no catalysts on the horizon to attract more people and fundamentally its just bad, even for penny standards. the only indicator left are borrowing costs but that just might be due to the recent run making lenders lose a lot and insuring themselves from it preemptively

ryzetard

so whats your opinion on it? the gamble is that their earnings may be seeing an upside since the last year due to september news - if they landed some upfront payments from these deals so a catalayst MIGHT happen - or not. The rest is as I described, not that big of a public float, majority locked by insiders/private placements, big SI, only the days to cover could be at least 2 or 3 to make it a very good squeeze candidate (still could happen, it would just be short lived if low DTC).

ryzetard

I think 4.3 is a good support level as well, keeps rebounding there. It will pop with another catalyst i think if this stock retains both high short interest and DTC. They wont go bankrupt any time soon and are undergoing some changes so i intend to keep it for some time, no daytrading or timing the market.

ryzetard

FLWS has just appointed a new veteran CIO, new CEO this year and hopefully there are some good news coming from the shareholder meeting regarding their new strategies and tech integration. Aside from that it has one of the stronger short squeeze setups due to both high SI (at least 30% or even up to 80% depending on the sources) and very high DTC (at least a week) values which are the most important factors , uavs has nothing going for it just like CVU - i dont understand these two tickers getting hyped

Which_Perspective871

You just buy or sell on vibes w/ shorts & DTC? I made a composite indicator on tradingview which is 9 indicators put together. I use it to screen 4hr, 1d, & a custom 3d timeframe. When it signals (meaning all indicators give it a 👍) it has a high win rate.

Which_Perspective871

You just buy or sell on vibes w/ shorts & DTC? I made a composite indicator on tradingview which is 9 indicators put together. I use it to screen 4hr, 1d, & a custom 3d timeframe. When it signals (meaning all indicators give it a 👍) it has a high win rate.

ryzetard

i asked about SGBX and will do so again - what are you basing your float on when institutionals were selling, squeeze already happened, DTC swings between 0.1-0.5 and SI dropped as per nasdaq. what do you even expect there?

Sea_Conversation_440

Sorry did i mention BYND here like to compare DFLI to it? Short squeezes existed long before BYND, and the DD I posted was only about DFLI’s actual data, not a meme comparison..? If the short interest and DTC didn’t change dramatically, I wouldn’t have bothered. Its data im sharing so calm yourself, its called a DD buddy.

Sea_Conversation_440

DFLI Short Squeeze (Heres the current short data) * Short interest: **15.4M shares** * Days to Cover jumped: **3.09** * Off-exchange (dark pool) ratio now: **55%** * Borrow availability staying low * RS deadline approaching → increased volatility * Lower volume + rising DTC = shorts becoming more trapped Not saying it *will* squeeze, but all we need is more volume to get this over a dollar. Dfli may announce news within these 3 days as well. The shorts are basically trapped with this setup.

ryzetard

Question is - do you think a stock shorted at 95% with over a month worth of DTC would not start covering after an over 25% upside with a signifcant volume increase day to day? That free float is kinda sketchy, but it can still run i think.

jarstiffler

I did a DD on FLWS yesterday. New CIO announced yesterday; has experience with Amazon, Bed Bath Beyond, etc.. 95% short float. 35 DTC. Not super expensive to borrow yet, but with volume/pressure from retail, that will change. I like the set up.

jarstiffler

It’s ready. 35 DTC, 95% short.

jarstiffler

35 DTC now...

scarletrose4444

TLDR: I'm in a similar situation in that I want to sell my DTC (South Denver, Co) house, rent an apartment and potentially invest the equity until I either move in with a partner or buy something else without the highest level of work (approx 6 months, could do it for longer if it seems smart). Single mother, 2 kids, approx 50/50 with Dad but I do the heavy lifting when it comes to school costs and extracurriculars. The yard and maintenance is killing me. I have founded a startup and would prefer not to have the cost of maintenance, insurance, property taxes, hoa ($1800p.a.) etc over my head. Thinking about selling and investing the ~$600k take home, while I rent something smaller and more manageable so I can use my spare time developing my business. I've been reading this and other similar posts and most suggest six months is too short a time to be investing, and too risky in this climate. My thoughts are to park the money but I don't want to be foolish and too risk averse if there is an intelligent play out there that I should be considering. I appreciate any advice.

Bojangles315

That is incorrect lmfao. They are recorded in book value, yes. in street name... at the DTCC, not the DTC. that is, in the broker dealers name. they are owned by the brokerage firm with you as a beneficial owner. not even going to explain an Omnibus or full disclosure basis. the company does not have your name, only the firm. the accounts are numbered, and the people are numbered. proxies and such are delivered by the firm on behalf of the corporation SIPC only kicks in for liquidation of a firm. lost/misplaced securities are handled during the count. they don't involve the SIPC whatsoever. once the count is done, which is a FINRA required thing for firms, it is taken against the firms net capital requirements. 25% at 7 days, 50% at 14, 75% at 21, and 100% at 28 days. the number of days is based on buy in/sell out requirements. this is derived from the clearing requirements. t+4 for normal transactions, all the way up to T+35 or even when issued transactions. Fidelity bonds would then come into play in the event of fraud. Fidelty bond requirements are based on net capital requirements. there is no such thing as a series 1. a series 4 is an options principal and does not apply here. a series 3 is a futures/commodities exam and would not apply here, a series 2 was a non registered exam and discontinued and would not apply here. What I have, series 7. general securities registered rep exam. series 99 is an operations professional registered rep exam which deals with this, a series 24 is a registered principals exam which deals with exactly this and net capital requirements for managing a firm, and a series 66 is a registered rep securities states law exam.

serendipitySR

Starlink - trillion dollars market DTC- trillion dollars market (after Echostar acquisition). Space data center - in development. Starship will make it happen. Need anything else? Starshield, Artemis, moon base, space tourism

Alarmed_Sell_1583

The reported float includes insiders, preferred structures, and locked blocks. Once you remove what doesn’t circulate, the tradable supply tightens to roughly 500k to 900k and that is the liquidity the market actually prices. DTC follows that scarcity, not the headline float. I am here to clarify the structure, not to shift your conviction. The market will speak for both of us!

Kooky-Repeat-5402

Although you’re mostly correct, the 1.55M which you state are ‘paralysed’ and this does show a bullish long term signal, the DTC still remain incredibly low for Squeeze and with 14M trading volume, it’s still manageable by shorts 933,339 short shares divided by 14,000,000 daily volume equals a DTC of 0.06 days(0.32 reported) The volume is currently too high to be a 'trap'. A high borrow fee (400%) is pain, but a DTC below 1 is freedom For this to squeeze it needs volume to dry up and DTC rise to tap shorts.

Lollooomm

Would dilute like the grappa in my morning coffee… (DTC is low, float% in short positions is not crazy high and BMNR is apparently a frequent new-share issuer) is not high, sorry brother… I personally believe in a soon to be Ubisoft Entertainment SA short-squeeze once they will provide more information on their model Feb 2026

macromind

Memestock or not, Playboy is a great reminder of how powerful a legacy brand can be if it figures out modern distribution and storytelling. There are so many ways they could lean into content, community and licensing that are way less risky than trying to moon the stock. There is a cool angle in how older brands reinvent their positioning for new channels (social, creator collabs, DTC etc.) that gets talked about here sometimes: https://blog.promarkia.com/

volckerwasright

It was definitely not a dead end this year. Rand Paul the hemp loophole guy? No thanks. A Democrat would be best for the sector but President Trump is by far better than the guy who would keep DTC sales and unlicensed stores open. These MSOs have invested heavily to be compliant with state laws.

whoa1ndo

I’ve been here. I made 30k from the initial squeeze and now see this shit is dead. “The 316M new BYND shares are already free-float since Oct 17. They were issued under Rule 144A (unregistered but QIB-eligible). The contractual lock-up expired on Oct 16 at 5 PM ET, so on the next trading day (Oct 17) the restricted CUSIP flipped to the unrestricted CUSIP via DTC and bondholders could sell freely. You can see it in real time: some funds already dumped (Context Partners went from 5.2 % → 0 %, D.E. Shaw from 8 % → 2.3 %, etc.).bynd site

whoa1ndo

“The 316M new BYND shares are already free-float since Oct 17. They were issued under Rule 144A (unregistered but QIB-eligible). The contractual lock-up expired on Oct 16 at 5 PM ET, so on the next trading day (Oct 17) the restricted CUSIP flipped to the unrestricted CUSIP via DTC and bondholders could sell freely. You can see it in real time: some funds already dumped (Context Partners went from 5.2 % → 0 %, D.E. Shaw from 8 % → 2.3 %, etc.)

Difficult_Winner_777

Look at this wacky ass chart. That is microfloat mechanics in action. Everyone is staring at one Fintel update like the float magically teleported into the millions overnight. Relax. NASDAQ just pushed the 11/25 short interest update and they are still using a 0.18M float. That matches the SEC filings. Nothing in the filings changed. No new issuance. No dilution valve. Fintel just swapped data vendors and half the sub had a panic attack. And before anyone forgets, the SEC math already pinned the effective float at roughly 0.40M. This came straight from the 10-Q, the PRE 14A, and the 424B filings. Outstanding count minus locked insider blocks minus restricted shares minus the registration delays on the S-1 leaves a circulating supply that is basically a dinner plate. That is why the chart levitates on buying and falls on air pockets. There is almost nothing actually trading. The drop from 1.4M short to 0.93M short is not shorts “winning.” You do not unwind ~500K short shares in a book this tiny without the chart turning into a blender. Instead the tape barely moved. That usually means shorts shifted exposure off the main tape between reporting channels. HKD did the same thing. The official SI cooled off while daily FINRA short volume stayed on fire. Now look at the actual mechanics: • DTC is at 0.02 • CTB is still in the 400% range • Lender availability keeps slamming to 0 • FINRA short volume stays above 50% every day • The price moves on crumbs of volume because the book is tiny That is microfloat physics. Not fear. Not mass selling. Just a cramped supply trying to absorb synthetic pressure. If shorts were actually done you would see CTB collapse, availability normalize, and FINRA short volume crater. None of that is happening. The tape is still stressed. The liquidity is still thin. The filings still confirm a tiny float. The daily metrics look like a rerun of HKD before its unwind. Nothing fundamental changed. Only the loudest people did.

icehole505

I think they like what AI investment is doing for them in the short term (creating a frothy market), and theyre sniffing their own AGI farts in the long term.. I don’t see where any of it turns into a meaningful ($100b+ annually) revenue line for Google though. Netflix does $50b revenue annually. If the medium term AI marketplace looks like a pile of DTC subscription plans, there’s just not enough money there to justify the expense

HofT

I looked at the filings you sent. None of them actually prove that the October shares are currently in the public float. The April and July filings only show when the warrants and preferred stock were created and when they became Series B preferred, not when those preferred shares were converted into common stock that is free-trading today. A preferred share becoming “Series B” in July does not start a Rule 144 holding period unless that specific security was issued to the holder at that exact time, and the filing does not show the acquisition date for each investor or the delivery date from the transfer agent. The S-1 you linked was withdrawn and never went effective, so it cannot make any shares tradable. Without an effective registration statement, the only path for those converted October shares to become tradable is Rule 144, which still requires a legend removal and a legal opinion issued to the transfer agent. The company has not filed anything showing that a legend was removed or that the transfer agent delivered unrestricted common shares into DTC. Nothing in what you sent shows that the 4.9M October shares were actually converted into unrestricted common stock and deposited into the float. It only shows the existence of the preferred stock and the terms of the offering. That is not the same as proof that the preferred shares were converted into free-trading common shares in October. Finally, market behaviour does not prove a 5M float. A high-volume day can come entirely from internalization, dark-pool routing, and recycling of the same shares over and over. The borrow fee staying above 400 percent, availability stuck at zero, and spreads behaving thin are all signs of constrained borrowable supply, not a wide float. So far, the filings you sent still do not demonstrate that the October shares are currently in the float.

Awkward_Profit_5203

I don't think this is how DTC works man 😭😭😭

thereal_horatio

Can you explain: “once DTC drops under 1–2 days, covering becomes mandatory” ?

AirNovel78350

mate if you followed squeeze stocks you know for sure DTC doesnt matter much on squeeze

Delly2times

Listen man, I’m just expressing my opinion on what I’m seeing as far as sentiment through boards and reddit, I’ve watched NFE for the last month, it’s had potential for a while and has been beaten down continually, I understand why, . You can see where the herd moves, the short interest is extremely high, and the cost to borrow is spiking (~93% CTB, 47% SI, ~6 DTC) I get what you’re saying about “reddit warriors” but at some point, whether you give a shit about the “reddit warriors” or not, you have to respect those numbers. Debt, no debt, dilution is always a risk with pennies, that’s inherent. Do your own research, we all have opinions and thoughts, it was simply just mine. Take a look around reddit, I’m seeing a lot of arrows. Best of luck in your trading, hopefully everyone gets rich tomorrow somehow. Unless you’re a bear, then in that case, daddy needs a new rug🎅🏼

MethFistHo

Denver is a shell of what it was pre-covid. Downtown became expensive and full of homeless so people stopped coming downtown. There are plenty of cool places to hang out in Arvada, Wheat ridge, DTC, Parker, etc. so there's really nothing bringing people downtown other than for sports.

GullibleTangerine698

DTC has been around that for last 3 days. They can exit on paper , but it would spike the price a lot more when they exit at this price. Idk the ceiling tho. Thanks for looking out, if its genuine.

Top_Satisfaction_124

ok guys... so the stock that shall not be names: the short interest is going down fast and DTC is low. On the surface it seems bad for a squeeze, but this is the exact conditions before the fake meat company mooned. The covering causes a liquidity crisis because covering literally puts buying pressure on the stock. NFA, but just my observation,.

GullibleTangerine698

DTC ignores liquidity and volatility. It is a math calculation using SI and Volume. In real life, shorts cannot all cover at once because there are not enough free-trading shares available. When multiple shorts try to buy back at the same time to try to cover in that time frame /volume frame, the price will still technically explode. So even though “days to cover” says 0.02, real covering could take hours or days depending on some factors like: • liquidity - shares to borrow - free trading shares • Overall volume on the day • buying pressure (Buying volume) • forced buy-ins at the price. margin calls etc. And all of this can spike price.

Difficult_Winner_777

DTC only needs to be 7+ on big-float plays like GME. On microfloat plays, it does the opposite it collapses toward zero because shorts are recycling the same tiny supply all day just to stay alive. HKD’s real DTC was basically zero before it nuked upward. SGBX at 0.12 isn’t safety. It’s the same microfloat choke-point forming.

Difficult_Winner_777

If you look at it in pure math terms, DTC collapsing is exactly what you expect in a microfloat squeeze, whether it was HKD in 2022 or SGBX now. DTC is just: Days to cover = Short interest ÷ Average daily volume For SGBX right now, rough numbers are: Short interest ≈ 1.4M Volume on the big days ≈ 10 to 12M So: 1.4M ÷ 12M ≈ 0.12 days to cover That does not mean shorts are safe. It means they’re churning volume like crazy. You can hit 0.12 DTC in two ways: 1. Shorts actually close into real liquidity (SI drops, CTB drops, borrow refills). 2. Shorts recycle the same float back and forth all day to keep price pinned (SI stays high, CTB stays insane, borrow stays at 0). What we see in SGBX is case 2: CTB ~500%, borrowable shares stuck at 0, FINRA short volume 40–60%. That’s not shorts “easily covering,” that’s shorts spinning the wheels on a tiny float. With HKD there isn’t clean public DTC data from the blow-off period, but mechanically it was the same pattern: float was microscopic, volume went vertical, and any attempt to cover size in a low-float book sent it straight from 13 to 2555. Near-zero DTC is just the math version of that same situation.

Difficult_Winner_777

DTC doesn’t measure whether shorts can cover It only measures how much volume was reported. When most of that volume is shorts recycling the same shares through dark pools and internalization, DTC collapses even though they’re still completely trapped. If shorts actually had real liquidity to close, CTB wouldn’t be ~500%, borrow wouldn’t be zero, and SI wouldn’t be triple the float. The 40% day wasn’t covering It was fuckin synthetic churn to defend the position. The real move starts when the recycled volume stops and the float stops rotating.

Difficult_Winner_777

Nobody has reliable official “DTC right before liftoff” numbers for HKD. Most services only show current data or backward-looking estimates, and Markit was reporting HKD’s short interest as less than 0.1% of OS during the run, which was obviously nonsense given how it traded. What we do know is that HKD’s float was microscopic, volume went vertical, and any attempt to cover in size sent it straight up in other words, the effective days-to-cover was basically zero. SGBX showing 0.12 DTC now is the same mechanical signal: shorts are sitting on a tiny float and can only survive by churning intraday volume. So we cannot say “HKD had exactly 0.12 DTC,” but we can say that this kind of near-zero DTC is exactly what you see right before a microfloat squeeze blows up.

Difficult_Winner_777

Every claim you made falls apart the moment you compare it to the actual SEC filings instead of assumptions. 1. “If the filing doesn’t say restricted, shares must be unrestricted.” Completely false. In U.S. securities law, shares are restricted by default unless they are issued under a registration statement or qualified exemption. The 10-Q does not reference any registration statement, legal opinion, shelf takedown, or Rule 144 seasoning. You cannot claim unrestricted with zero legal basis. 2. “They can dilute millions before December 29.” Directly contradicted by Nasdaq Rule 5635(d) and every financing agreement SGBX has. They all contain 4.99 percent beneficial-ownership caps and 19.99 percent issuance limits. PRE 14A Proposal 8 explicitly states new authorized shares only exist after shareholder approval and after the Certificate of Amendment is filed. 3. “Float is definitely 5M+ and Fintel is wrong.” If float were 5M+, we would not have 500–600 percent CTB, zero borrow availability, 40–60 percent short-volume ratios, and HKD-style intraday moves. The market behavior contradicts your claim. Float updates slow, but the liquidity profile does not lie. This is microfloat behavior, not multi-million-float behavior. 4. “Short interest % float is meaningless.” It’s meaningless only if float magically expanded. You have provided no evidence that any of the October shares entered float. Again, no registration, no prospectus supplement, no Rule 144 notice. If those shares were truly free trading, lending supply wouldn’t be zero. 5. “Borrow fee doesn’t prove microfloat.” Correct, borrow fee alone doesn’t — but borrow fee + zero availability + high SI + high short-volume + DTC collapse absolutely does. That combination only exists when borrowable supply is tiny. If float were large, CTB would normalize instantly. 6. “HKD comparison is invalid.” HKD comparison is mechanical, not fundamental. HKD ran because supply was locked, float was tiny, and shorts had no exit. SGBX has locked dilution until Dec 29, a microfloat until registration, and SI multiple times the tradable float. The structures are analogous, regardless of jurisdiction. 7. “Conversions are usually free trading.” Not unless they were registered or specifically exempted. You have not cited the registration statement because none exists. The 10-Q does not connect the October conversions to the October prospectus. Your argument is assumption, not evidence. 8. “Shorts can cover intraday.” Only if shares exist to cover with. They don’t. That’s why CTB is 500 percent, availability is zero, and DTC sits near zero. Shorts are recycling volume, not closing positions. Big difference. Bottom line: Your entire rebuttal is built on assumptions that contradict the actual filings, Nasdaq rules, and observable market microstructure. I’m quoting law and SEC text. You’re guessing. Only one of those survives contact with reality. This guy just asked chatgpt to form a rebuttal Is this the best shorts can do? Im fucking bullish to the MAXIMUM NOW

Difficult_Winner_777

The borrow-loan percentage only reinforces the point. If nine percent of all outstanding shares are already loaned out and borrow availability is still basically zero, that tells you the float is tiny and fully spoken for. As for catalysts, the company already signed a definitive merger with New Asia Holdings, which owns Olenox’s drilling operations and Machfu’s industrial IoT platform. The final step of that merger converting the preferred into common is literally on the Dec 29 ballot. Until that vote and the amendment filing, no new shares can legally hit the market, which is why shorts are stuck recycling volume and why DTC keeps collapsing.

Ambitious_Cress8002

By definition, DTC assumes volume is real. If volume is fair-market volume, then yes: low DTC = shorts can exit easily. How do we know volume doesn't reflect real liquidity?

Difficult_Winner_777

DTC being low does not mean shorts can easily exit. It means shorts are relying almost entirely on intraday volume and dark pools to avoid being forced to exit. This exact pattern appeared in HKD before it launched. When the float is tiny and the short interest is larger than the float, the only way shorts survive is by constantly recycling the same borrowed shares. That creates artificial volume. The volume looks big, so DTC drops, but the real borrowable supply never increases. You can see that in SGBX with zero to forty thousand shares available and five hundred percent CTB. In HKD, days to cover fell to almost nothing while the stock was under suppression. Once the recycling loop broke and shorts could no longer hide inside the volume, the price exploded even though the DTC number was low. That is what a collapsing DTC actually means in a microfloat squeeze. It means shorts are using volume as a shield, not that they are safe. If the float is small, the borrow pool is empty, the CTB is extreme, and the dilution valve is closed until a specific date, a low DTC is simply the pressure building before the break.

_hiddenscout

Disney reports Q4 adjusted EPS $1.11, consensus $1.02 \-- Q4 revenue $22.5B, consensus $22.78B. \-- Sees 'double digit adjusted EPS growth' in FY26 vs. FY25, consensus $6.49. \-- Sees 'double digit adjusted EPS growth' in FY27 vs. FY26 Q1 segment guidance Fiscal 2026: \-- Entertainment: DTC SVOD operating income of approximately $375 million. \-- Theatrical slate comparisons to drive an adverse impact to segment operating income of $400 million compared to Q1 fiscal 2025. \-- Lower political advertising revenue of $140 million compared to Q1 fiscal 2025. \-- Unfavorable comparison to $73 million of Star India operating income in Q1 fiscal 2025. \-- Experiences: $90 million in pre-opening expenses at Disney Cruise Line, driven by the Disney Destiny and Disney Adventure. \-- $60 million in dry dock expenses at Disney Cruise Line. Seems so long ago when there was that expression of don't bet against the mouse.

BrightLengthiness853

They've concluded their research they don't need to dilute - as mentioned in the DD. They are fully funded - $80m in the bank. News coming soon. Short DTC 8.6 days.